Alzheimer's disease is a neurodegenerative disease. Recently, alterations in the mesolimbic system have been described, especially in the nucleus accumbens (nAc). We found that intracellular accumulation of Aβ was higher in neurons of the APP/PS1 mice at 10 and 15 days in vitro. At 15 days in vitro (DIV), APP/PS1 accumbal neurons showed alterations in synaptic transmission and neuronal excitability. Specifically, there was an increase in AMPAergic synaptic currents, which was sensitive to the application of NASPM, suggesting a critical role for calcium-permeable AMPA receptors (CP-AMPARs). Our study indicates that this neuronal culture model accurately replicates alterations in the early stages of AD.
SelkoeDJHardyJ. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med2016; 8: 595–608.
3.
RussoSJNestlerEJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci2013; 14: 609–625.
4.
D'AmelioMNisticoR. Unlocking the secrets of dopamine in Alzheimer's disease. Pharmacol Res2018; 128: 399.
5.
D'AmelioMPuglisi-AllegraSMercuriN. The role of dopaminergic midbrain in Alzheimer's disease: translating basic science into clinical practice. Pharmacol Res2018; 130: 414–419.
6.
NieXSunYWanS, et al.Subregional structural alterations in hippocampus and nucleus accumbens correlate with the clinical impairment in patients with Alzheimer's disease clinical spectrum: parallel combining volume and vertex-based approach. Front Neurol2017; 8: 399.
7.
NobiliALatagliataECViscomiMT, et al.Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease. Nat Commun2017; 8: 14727.
8.
Fernandez-PerezEJGallegosSArmijo-WeingartL, et al.Changes in neuronal excitability and synaptic transmission in nucleus accumbens in a transgenic Alzheimer's disease mouse model. Sci Rep2020; 10: 19606.
9.
de MedeirosLMDe BastianiMARicoEP, et al.Cholinergic differentiation of human neuroblastoma SH-SY5Y cell line and its potential use as an in vitro model for Alzheimer's disease studies. Mol Neurobiol2019; 56: 7355–7367.
10.
XieDDengTZhaiZ, et al.The cellular model for Alzheimer's disease research: pC12 cells. Front Mol Neurosci2022; 15: 1016559.
11.
FathTKeYDGunningP, et al.Primary support cultures of hippocampal and substantia nigra neurons. Nat Protoc2009; 4: 78–85.
12.
JankowskyJLFadaleDJAndersonJ, et al.Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet2004; 13: 159–170.
13.
ChiuKLauWMLauHT, et al.Micro-dissection of rat brain for RNA or protein extraction from specific brain region. J Vis Exp2007; 7: 269.
14.
AguayoLGWhiteG. Effects of nerve growth factor on TTX- and capsaicin-sensitivity in adult rat sensory neurons. Brain Res1992; 570: 61–67.
15.
Gonzalez-SanmiguelJBurgosCFBascunanD, et al.Gabapentin inhibits multiple steps in the amyloid beta toxicity cascade. ACS Chem Neurosci2020; 11: 3064–3076.
16.
Fernandez-PerezEJSepulvedaFJPetersC, et al.Effect of cholesterol on membrane fluidity and association of Abeta oligomers and subsequent neuronal damage: a double-edged sword. Front Aging Neurosci2018; 10: 226.
17.
Fernandez-PerezEJMunozBBascunanDA, et al.Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers. Aging Cell2021; 20: e13455.
18.
YoumansKLTaiLMKanekiyoT, et al.Intraneuronal Abeta detection in 5xFAD mice by a new Abeta-specific antibody. Mol Neurodegener2012; 7: 8.
19.
KayedRHeadEThompsonJL, et al.Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science2003; 300: 486–489.
20.
GuoCMaYY. Calcium permeable-AMPA receptors and excitotoxicity in neurological disorders. Front Neural Circuits2021; 15: 711564.
21.
TsubokawaHOguroKMasuzawaT, et al.Effects of a spider toxin and its analogue on glutamate-activated currents in the hippocampal CA1 neuron after ischemia. J Neurophysiol1995; 74: 218–225.
22.
Armijo-WeingartLSan MartinLGallegosS, et al.Loss of glycine receptors in the nucleus accumbens and ethanol reward in an Alzheimer's disease mouse model. Prog Neurobiol2024; 237: 102616.
23.
KrashiaPNobiliAD'AmelioM. Unifying hypothesis of dopamine neuron loss in neurodegenerative diseases: focusing on Alzheimer's disease. Front Mol Neurosci2019; 12: 123.
24.
WuXRZhuXNPanYB, et al.Amygdala neuronal dyshomeostasis via 5-HT receptors mediates mood and cognitive defects in Alzheimer's disease. Aging Cell2024; 23: e14187.
25.
KellyLSeifiMMaR, et al.Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer's patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability. Neuropathol Appl Neurobiol2021; 47: 488–505.
26.
Soares-CunhaCde VasconcelosNAPCoimbraB, et al.Nucleus accumbens medium spiny neurons subtypes signal both reward and aversion. Mol Psychiatry2020; 25: 3241–3255.
27.
FlorescoSB. The nucleus accumbens: an interface between cognition, emotion, and action. Annu Rev Psychol2015; 66: 25–52.
28.
MastersMCMorrisJCRoeCM. “Noncognitive” symptoms of early Alzheimer disease: a longitudinal analysis. Neurology2015; 84: 617–622.
29.
Targa Dias AnastacioHMatosinNOoiL. Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?Transl Psychiatry2022; 12: 257.
30.
PilottoAGalliASalaA, et al.Dopaminergic deficits along the spectrum of Alzheimer's disease. Mol Psychiatry2025; 30: 3069–3076.
31.
SalaACaminitiSPPresottoL, et al.In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases. Alzheimers Res Ther2021; 13: 187.
32.
SerraLD'AmelioMDi DomenicoC, et al.In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease. Neurobiol Aging2018; 72: 72–82.
33.
WelikovitchLADo CarmoSMagloczkyZ, et al.Evidence of intraneuronal Abeta accumulation preceding tau pathology in the entorhinal cortex. Acta Neuropathol2018; 136: 901–917.
34.
OkazawaH. Ultra-early phase pathologies of Alzheimer's disease and other neurodegenerative diseases. Proc Jpn Acad Ser B Phys Biol Sci2017; 93: 361–377.
35.
WangJShenYCongQ, et al.Ultra-early detection and treatment of Alzheimer's disease through sonoporation-mediated intracellular delivery of ICG-labeled aducanumab. Nano Today2024; 57: 102396.
36.
Cull-CandySKellyLFarrantM. Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond. Curr Opin Neurobiol2006; 16: 288–297.
37.
WhitcombDJHoggELReganP, et al.Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus. Sci Rep2015; 5: 10934.
38.
GuoCWenDZhangY, et al.Amyloid-beta oligomers in the nucleus accumbens decrease motivation via insertion of calcium-permeable AMPA receptors. Mol Psychiatry2022; 27: 2146–2157.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
